AU2001292993A1 - Compositions for reducing side effects in chemotherapeutic treatments - Google Patents
Compositions for reducing side effects in chemotherapeutic treatmentsInfo
- Publication number
- AU2001292993A1 AU2001292993A1 AU2001292993A AU9299301A AU2001292993A1 AU 2001292993 A1 AU2001292993 A1 AU 2001292993A1 AU 2001292993 A AU2001292993 A AU 2001292993A AU 9299301 A AU9299301 A AU 9299301A AU 2001292993 A1 AU2001292993 A1 AU 2001292993A1
- Authority
- AU
- Australia
- Prior art keywords
- compositions
- side effects
- reducing side
- chemotherapeutic treatments
- chemotherapeutic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US23514100P | 2000-09-25 | 2000-09-25 | |
US60/235,141 | 2000-09-25 | ||
PCT/US2001/029754 WO2002026262A2 (en) | 2000-09-25 | 2001-09-24 | Compositions for reducing side effects in chemotherapeutic treatments |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2001292993A1 true AU2001292993A1 (en) | 2002-04-08 |
Family
ID=22884262
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001292993A Abandoned AU2001292993A1 (en) | 2000-09-25 | 2001-09-24 | Compositions for reducing side effects in chemotherapeutic treatments |
Country Status (4)
Country | Link |
---|---|
US (2) | US6642205B2 (en) |
EP (1) | EP1363673A2 (en) |
AU (1) | AU2001292993A1 (en) |
WO (1) | WO2002026262A2 (en) |
Families Citing this family (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6680306B2 (en) * | 2001-06-21 | 2004-01-20 | Glycogenesys, Inc. | Method for enhancing the effectiveness of cancer therapies |
US7776314B2 (en) | 2002-06-17 | 2010-08-17 | Grunenthal Gmbh | Abuse-proofed dosage system |
JP2007531697A (en) * | 2003-07-11 | 2007-11-08 | プロ−ファーマシューティカルズ,インコーポレイティド | Compositions and methods for the delivery of hydrophobic drugs |
DE10361596A1 (en) | 2003-12-24 | 2005-09-29 | Grünenthal GmbH | Process for producing an anti-abuse dosage form |
DE10336400A1 (en) | 2003-08-06 | 2005-03-24 | Grünenthal GmbH | Anti-abuse dosage form |
DE102004032051A1 (en) | 2004-07-01 | 2006-01-19 | Grünenthal GmbH | Process for the preparation of a secured against misuse, solid dosage form |
US20070048228A1 (en) | 2003-08-06 | 2007-03-01 | Elisabeth Arkenau-Maric | Abuse-proofed dosage form |
DE102005005446A1 (en) | 2005-02-04 | 2006-08-10 | Grünenthal GmbH | Break-resistant dosage forms with sustained release |
US20050053664A1 (en) * | 2003-09-08 | 2005-03-10 | Eliezer Zomer | Co-administration of a polysaccharide with a chemotherapeutic agent for the treatment of cancer |
WO2005079314A2 (en) * | 2004-02-13 | 2005-09-01 | Pro-Pharmaceuticals, Inc. | Compositions and methods used to treat acne and candida |
DE102004032049A1 (en) | 2004-07-01 | 2006-01-19 | Grünenthal GmbH | Anti-abuse, oral dosage form |
US20080286251A1 (en) * | 2004-08-02 | 2008-11-20 | Propharmaceuticals, Inc. | Compositions and Methods for the Enhancement of Chemotherapy with Microbial Cytotoxins |
DE102005005449A1 (en) | 2005-02-04 | 2006-08-10 | Grünenthal GmbH | Process for producing an anti-abuse dosage form |
WO2008011216A2 (en) | 2006-05-16 | 2008-01-24 | Pro-Pharmaceuticals, Inc. | Galactose-pronged polysaccharides in a formulation for antifibrotic therapies |
JP5774853B2 (en) | 2008-01-25 | 2015-09-09 | グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング | Pharmaceutical dosage form |
WO2009135680A1 (en) | 2008-05-09 | 2009-11-12 | Grünenthal GmbH | Process for the preparation of an intermediate powder formulation and a final solid dosage form under usage of a spray congealing step |
CA2765971C (en) | 2009-07-22 | 2017-08-22 | Gruenenthal Gmbh | Hot-melt extruded controlled release dosage form |
AU2010275755B2 (en) | 2009-07-22 | 2014-04-24 | Grünenthal GmbH | Oxidation-stabilized tamper-resistant dosage form |
EP2611426B1 (en) | 2010-09-02 | 2014-06-25 | Grünenthal GmbH | Tamper resistant dosage form comprising inorganic salt |
PL2611425T3 (en) | 2010-09-02 | 2014-09-30 | Gruenenthal Gmbh | Tamper resistant dosage form comprising an anionic polymer |
PT2736495T (en) | 2011-07-29 | 2017-11-30 | Gruenenthal Gmbh | Tamper-resistant tablet providing immediate drug release |
HUE034710T2 (en) | 2011-07-29 | 2018-02-28 | Gruenenthal Gmbh | Tamper-resistant tablet providing immediate drug release |
WO2013127831A1 (en) | 2012-02-28 | 2013-09-06 | Grünenthal GmbH | Tamper-resistant dosage form comprising pharmacologically active compound and anionic polymer |
MX362357B (en) | 2012-04-18 | 2019-01-14 | Gruenenthal Gmbh | Tamper resistant and dose-dumping resistant pharmaceutical dosage form. |
US10064945B2 (en) | 2012-05-11 | 2018-09-04 | Gruenenthal Gmbh | Thermoformed, tamper-resistant pharmaceutical dosage form containing zinc |
WO2014130648A1 (en) | 2013-02-20 | 2014-08-28 | Galectin Therapeutics, Inc. | Method for treatment of pulmonary fibrosis |
SI2991683T1 (en) | 2013-05-02 | 2020-01-31 | Glykos Finland Oy | Conjugates of a glycoprotein or a glycan with a toxic payload |
EP3003283A1 (en) | 2013-05-29 | 2016-04-13 | Grünenthal GmbH | Tamper resistant dosage form with bimodal release profile |
EP3003279A1 (en) | 2013-05-29 | 2016-04-13 | Grünenthal GmbH | Tamper-resistant dosage form containing one or more particles |
JP6449871B2 (en) | 2013-07-12 | 2019-01-09 | グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング | Anti-modified dosage form containing ethylene-vinyl acetate polymer |
CN106572980A (en) | 2014-05-12 | 2017-04-19 | 格吕伦塔尔有限公司 | Tamper resistant immediate release capsule formulation comprising tapentadol |
EP3148512A1 (en) | 2014-05-26 | 2017-04-05 | Grünenthal GmbH | Multiparticles safeguarded against ethanolic dose-dumping |
JP5924795B2 (en) | 2014-06-13 | 2016-05-25 | テンボロン オイ | Complex |
ES2785551T3 (en) | 2014-06-30 | 2020-10-07 | Glykos Finland Oy | Saccharide derivative of a toxic payload and its conjugates with antibodies |
EP3285745A1 (en) | 2015-04-24 | 2018-02-28 | Grünenthal GmbH | Tamper-resistant dosage form with immediate release and resistance against solvent extraction |
JP2018526414A (en) | 2015-09-10 | 2018-09-13 | グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング | Protection against oral overdose with abuse-inhibiting immediate release formulations |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5350836A (en) * | 1989-10-12 | 1994-09-27 | Ohio University | Growth hormone antagonists |
US5639737A (en) * | 1991-11-04 | 1997-06-17 | Co Enzyme Technology Ltd. | Method and compositions for treating malignant tumors and inhibiting growth and metastases of malignant tumors |
DE4236237A1 (en) * | 1992-10-27 | 1994-04-28 | Behringwerke Ag | Prodrugs, their preparation and use as medicines |
DE19524515A1 (en) * | 1995-07-05 | 1997-01-09 | Deutsches Krebsforsch | Saccharide conjugates |
-
2001
- 2001-09-24 WO PCT/US2001/029754 patent/WO2002026262A2/en active Search and Examination
- 2001-09-24 US US09/961,681 patent/US6642205B2/en not_active Expired - Lifetime
- 2001-09-24 EP EP01973411A patent/EP1363673A2/en not_active Withdrawn
- 2001-09-24 AU AU2001292993A patent/AU2001292993A1/en not_active Abandoned
-
2003
- 2003-06-24 US US10/354,750 patent/US20030229028A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US6642205B2 (en) | 2003-11-04 |
EP1363673A2 (en) | 2003-11-26 |
US20020068077A1 (en) | 2002-06-06 |
WO2002026262A3 (en) | 2003-07-10 |
WO2002026262A2 (en) | 2002-04-04 |
WO2002026262A9 (en) | 2003-03-20 |
US20030229028A1 (en) | 2003-12-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2001292993A1 (en) | Compositions for reducing side effects in chemotherapeutic treatments | |
AU2778801A (en) | Antisense compositions and methods | |
AU2001293309A1 (en) | Crosstalk reduction in constrained wiring assemblies | |
AU2001241098A1 (en) | Composition | |
AU2001267878A1 (en) | Hypoglycemics | |
AUPR551901A0 (en) | Improvements in packaging | |
AU2002236455A1 (en) | Synergistic ecta compositions | |
AUPQ634300A0 (en) | Synergistic formulations | |
AU2001275201A1 (en) | Acne-treating composition | |
AU2001272655A1 (en) | Improvements in valves | |
AU2002301358A1 (en) | Improvements in Transmissometers | |
AU2002301354A1 (en) | Improvements in Transmissometers | |
AUPQ644900A0 (en) | Preserving compositions | |
AU2001287852A1 (en) | Composition | |
AU2001231107A1 (en) | Improved lactational | |
AU2002211741A1 (en) | Surface modifying composition | |
AU2001295991A1 (en) | Compositions for improving lipids in blood | |
AU2001287732A1 (en) | Copolycarbonate-based composition | |
AU2001262163A1 (en) | Composition | |
AU2002238794A1 (en) | Methods and compositions involved in groucho-mediated differentiation | |
AU2002221748A1 (en) | Stain treatment composition | |
AU2387201A (en) | Improvements in transceivers | |
AU7621800A (en) | Methods and compositions for reducing sympathomimetic-induced side effects | |
AU2001285568A1 (en) | Mucin | |
AU4899901A (en) | Leading in roller box (variants) |